Monday, 16 Sep 2019

You are here

Need for Pre-operative Hyperglycemia Testing Prior to Total Joint Replacement

JAMA reports on a  large Medicare cohort study showing that amongst patients undergoing total joint replacement (TJR), preoperative HbA1c testing was performed in 26% to 43% of patients with diabetes and in only 5% of those without diabetes. Importantly research has shown that an elevated HbA1c level is associated with postoperative complications. 

 

It is estimated that ther aer more than one million TJRs are performed annually in the United States.  Given a well known connnection between osteoarthritis and diabetes and that suboptimal glucose control preoperatively is associated with poor TJR outcomes, researchers at Brigham and Women’s Hosptial set our to assess the frequency of hemoglobin A1c (HbA1c) testing in the 90 days prior to surgery among Medicare enrollees, who were 65 years or older.

A total of 465 566 patients met the inclusion criteria, with a mean age ranged from 73 to 75 years.

In the 90 days prior to TJR, HbA1c testing occurred in: 

  • 4.9% of non-diabetic patients
  • 25.8% of those with diabetes not receiving medication
  • 39.0% of those with diabetes receiving noninsulin medications
  • 43.4% of those with diabetes receiving insulin.

Similar trends with serum glucose testing was seen, with 37.2% tested if they did not have diabetes increasing up to 50.2% in those with diabetes receiving insulin.

These findings suggest that assessing HbA1c would be a potentially important preoperative safety measure in patients undergoing TJR.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Weight Loss Cuts Hospital Stays for Obese TKA Patients

Morbidly obese patients who lost 20 lbs before total knee arthroplasty (TKA) cut their hospital stays by about 1 day, and were 76% less likely to have an extended hospital stay, research showed. 

High-Dose Vitamin D: No Help for Bone Health

Vitamin D might not be much help for strengthening bones among healthy adults without osteoporosis, Canadian researchers reported, even at doses far higher than recommended daily allowances. In a clinical trial assessing three levels of daily vitamin D supplementation -- 400 IU, 4,000 IU, and 10,000 IU -- radial volumetric bone mineral density was significantly lower among those (ages 55-70) taking higher doses for 3 years, according to Steven Boyd, PhD, of the University of Calgary in Canada, and colleagues.

Osteoporosis Tx: Good for Bones, but Not for Cutting Death Risk

Osteoporosis treatments were not linked with reduced overall mortality, according to a meta-analysis of placebo-controlled trial data.

Looking at data from 38 clinical trials, there was no significant association found between all drug-based osteoporosis treatments and overall mortality rate (risk ratio 0.98, 95% CI 0.91-1.05), reported Steven Cummings, MD, of the San Francisco Coordinating Center, and colleagues.

Bisphosphonate Use Associated with Reduced Mortality

The Journal of Bone and Mineral Research (JBMR) has published a report showing that a reduction in the rate of bone loss by nitrogen bisphosphonates was associated with a 40% lower mortality risk.

Accelerated bone loss has been shown to be an independent predictor of mortality risk, but the relationship between bisphosphonates, bone loss, and mortality is unknown.

Partial or Total Knee Replacement for Osteoarthritis?

Lancet has reported on a clinical trial comparing total knee replacement (TKR) and partial knee replacement (PKR) in late-stage isolated medial compartment knee osteoarthritis patients finding that both TKR and PKR are equally effective, PKR should be considered the first, because of lower costs and better cost-effectiveness.